Biopharming is back, report finds
SAN FRANCISCO - Shielded by a federal process that limits public access to data, biotechnology companies are quietly pushing to splice more human genes into food crops after the practice was nearly abandoned last year, a Washington-based advocacy group said in a report released Wednesday.
2 June 2004
2 minute read
